CSIMarket Company Name, Ticker, Competitors, else..


Iovance Biotherapeutics inc   (NASDAQ: IOVA)
Other Ticker:  
 

Iovance Biotherapeutics inc

IOVA's Fundamental analysis



Looking into Iovance Biotherapeutics Inc growth rates, revenue grew by 6798.46 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 14

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 12.76 %

Iovance Biotherapeutics Inc net loss increased from $-113 millions, to $-116 millions in first quarter of 2025,

• More on IOVA's Growth


Iovance Biotherapeutics Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 17.6 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.1.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.2.


• More on IOVA's Valuation
 
 Total Debt (Millions $) 1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,575,400
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 3.74
 Tangible Book Value (Per Share $) 1.49

Iovance Biotherapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 17.6 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.1.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.2.

Iovance Biotherapeutics Inc Price to Book Ratio is at 0.86 lower than Industry Avg. of 1880.07. and higher than S&P 500 Avg. of 0.01

• More on IOVA's Valuation

•  Market Capitalization (Millions $) 659
•  Shares Outstanding (Millions) 323
•  Employees 135
•  Revenues (TTM) (Millions $) 213
•  Net Income (TTM) (Millions $) -375
•  Cash Flow (TTM) (Millions $) 37
•  Capital Exp. (TTM) (Millions $) -13
•  Total Debt (Millions $) 1
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 1,575,400
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 3.74
•  Tangible Book Value (Per Share $) 1.49

•  Market Capitalization (Millions $) 659
•  Shares Outstanding (Millions) 323
•  Employees 135
•  Revenues (TTM) (Millions $) 213
•  Net Income (TTM) (Millions $) -375
•  Cash Flow (TTM) (Millions $) 37
•  Capital Exp. (TTM) (Millions $) -13





  Ratio
•   Capital Ratio (MRQ) 4.49
•  Total Debt to Equity (MRQ) 0
•  Tangible Leverage Ratio (MRQ) 0.39
•  Asset Turnover Ratio (TTM) 0.24
•  Inventory Turnover Ratio (TTM) 3.63





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com